Amwill Health Care
43.00
+0.50(+1.18%)
Market Cap₹86.00 Cr
PE Ratio7.44
IndustryHealthcare
Company Performance:
1D+1.18%
1M-2.27%
6M+24.53%
1Y-28.69%
5Y-53.89%
View Company Insightsright
More news about Amwill Health Care
05Nov 25
Amwill Healthcare Reports 40% Profit Decline in H1 FY2026, Utilizes 67% of IPO Proceeds
Amwill Health Care's unaudited financial results for H1 FY2026 show a 40.55% decrease in profit to ₹387.40 lakhs, with revenue falling 8.43% to ₹2,120.50 lakhs. Total expenses increased by 19.59% to ₹1,733.90 lakhs, while earnings per share dropped 53.59% to ₹1.94. The company has utilized 67.27% of its IPO proceeds, with no deviations from the stated objectives. The remaining funds are invested in term deposits and current accounts.
 no imag found
30Jun 25
Amwill Health Care Announces Major Expansion Across Key Indian Markets
Amwill Health Care has revealed plans for significant business expansion into multiple Indian states including Maharashtra, Tamil Nadu, North East India, Chhattisgarh, and Madhya Pradesh. This strategic move aims to extend the company's reach and services to a broader customer base across diverse regions of India. The expansion targets a mix of developed and emerging markets, potentially tapping into underserved healthcare sectors and catering to varied demographics and healthcare needs.
 no imag found
Amwill Health Care
43.00
+0.50
(+1.18%)
1 Year Returns:-28.69%
Industry Peers
Sun Pharmaceutical
1,963.50
(-1.36%)
Divis Laboratories
8,585.00
(+6.57%)
Torrent Pharmaceuticals
5,050.00
(-1.42%)
Cipla
1,474.40
(+0.08%)
Zydus Life Science
1,121.00
(-0.51%)
Lupin
2,393.00
(-0.91%)
Mankind Pharma
2,483.00
(+0.54%)
Dr Reddys Laboratories
1,180.00
(+2.78%)
Laurus Labs
1,811.40
(-0.26%)
Aurobindo Pharma
1,554.70
(-1.61%)